Regencell Bioscience Holdings Limited

Healthcare

NASDAQ:RGC · NASDAQ Capital Market

Market Cap $9.81B Beta 1.64 P/E (TTM) -1332.9

$18.83 -3.50%

-$0.69 today

52W Low $9.39High $83.60

Vol 0.08M · Avg 0.13M

EPS (TTM)-$0.01

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+20.24%

Period High

$78.00

Period Low

$10.36

Latest

$18.83

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Axsome Therapeutics, Inc.

NASDAQ:AXSM

$13.21B

Masimo Corporation

NASDAQ:MASI

$9.42B

Nuvalent, Inc.

NASDAQ:NUVL

$9.07B

Cytokinetics, Incorporated

NASDAQ:CYTK

$8.70B

AptarGroup, Inc.

NYSE:ATR

$7.54B

Merus N.V.

MRUS

$6.83B

Grifols, S.A.

NASDAQ:GRFS

$6.50B

Abivax S.A.

NASDAQ:ABVX

$6.35B

Rhythm Pharmaceuticals, Inc.

NASDAQ:RYTM

$6.04B

Stevanato Group S.p.A.

NYSE:STVN

$4.66B

What is the latest RGC filing?

The latest filing shown is 4 dated May 29, 2026.

How many recent filings does RGC have?

Intrinsic Alpha currently shows 20 recent filings for RGC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.